International Journal of Dermatology · Published 2026-06-25 · DOI 10.1111/ijd.70558
Ioannis‐Alexios Koumprentziotis, Aikaterini Tsiogka, Ileana‐Afroditi Kleidona, Aristeidis Vaiopoulos, Alexander Stratigos, Stamatios Gregoriou
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Koumprentziotis, I., Tsiogka, A., Kleidona, I., et al. (2026). Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate‐to‐Severe Atopic Dermatitis: A 104‐Week, Real‐World, Retrospective Study. International Journal of Dermatology. https://doi.org/10.1111/ijd.70558